/

Sociétés

Me

Non vérifié

Merrimack Pharmaceuticals, Inc.

Ce que nous écrivons

FinanceIndustrieMédecine - Divers

2 communiqués de presse

Voir tous les communiqués de presse

09/05/2024

Finance

Industrie

Médecine - Divers

Merrimack Pharmaceuticals, Inc. Announces Anticipated Final Cash Dividend Amount of Initial Liquidating Distribution, Subject to Receipt of Stockholder Approval of Plan of Dissolution

Source

Merrimack Pharmaceuticals, Inc.

Émetteur

1.00

0

30/04/2024

Médecine - Divers

Merrimack Pharmaceuticals Announces Notification of Plan to Voluntary Delist Common Stock on NASDAQ Subject to Receipt of Stockholder Approval of Plan of Dissolution

Source

Merrimack Pharmaceuticals, Inc.

Émetteur

1.00

0

Followers

0

Compatibilité

0